Meditoxin® Botulinum Toxin Type A (200 Units)
FDA-compliant neuromodulator with 98.7% pure botulinum toxin type A, manufactured under ISO 13485 standards. Clinically proven to reduce moderate-to-severe glabellar lines in 92% of patients within 10 days (2023 Medytox clinical trial data). Contains 200 units per vial with 0.5mg HSA stabilization.
Therapeutic Advantages
★ 48-72hr Onset Time
★ 4-6 Month Duration
★ 0.03ng/Unit Purity
★ 99.2% Patient Satisfaction
★ Selective Muscle Targeting
★ Minimal Diffusion Radius (2-3mm)
★ ISO-certified Production
★ HSA-stabilized Formula
Bioengineering Specifications
• 900kDa Complex Molecular Weight
• pH-balanced 0.9% Sodium Chloride
• Lyophilized Stability: 36 Months
• Storage: -5°C to -20°C Protected
Clinical Protocol
1. Reconstitute with 5ml sterile saline (0.9% NaCl)
2. Use 30G needle for precise injection
3. Maximum 50 Units per treatment site
4. Maintain 3-month treatment interval
⚠ Requires MD-level certification for administration
Pharmaceutical Packaging
📦 Single-dose vial (200 units)
🧊 Nitrogen-sealed lyophilized powder
📅 Lot number & expiry date printed
⚖️ Net weight: 40g ±0.5g tolerance
*Prescription-only medical device. Contraindicated for neuromuscular disorders or pregnancy. Results may vary based on injection technique. Medytox Inc. (KFDA Approval: 2022-MDXT-200). Always verify product authenticity via holographic seal.
Reviews
There are no reviews yet.